Note:  All articles are the sole copyright of the respective publishers.  Materials are provided for educational purposes only. Downloading of materials constitutes an agreement that the materials are for personal use only.

2024 _______________________________________________________

1. Grodin, E. N., Montoya, A. K., Cruz, A., Donato, S., Baskerville, W.-A., & Ray, L. A. (2024). Identifying Treatment Responders to Varenicline for Alcohol Use Disorder Using Two Machine-Learning Approaches. Clinical Psychological Science, 12(1), 133-146. https://doi.org/10.1177/21677026231169922
2. Ray, L.A., Baskerville, WA., Nieto, S.J. et al. A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. Psychopharmacology 241, 543–553 (2024). https://doi.org/10.1007/s00213-023-06504-6
3. Kirsch, D. E., Ray, L. A., Wassum, K. M., & Grodin, E. N. (2024). Anterior cingulate and medial prefrontal cortex alcohol cue reactivity varies as a function of drink preference in alcohol use disorder. Drug and alcohol dependence, 256, 111123. https://doi.org/10.1016/j.drugalcdep.2024.111123
4. Kirsch, D.E., Belnap, M.A., Burnette, E.M. et al. Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender. Curr Addict Rep 11, 81–93 (2024). https://doi.org/10.1007/s40429-023-00535-x
5. Nieto, S.J., Du, H., Meredith, L.R. et al. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy. Psychopharmacology 241, 1679–1689 (2024). https://doi.org/10.1007/s00213-024-06589-7
6. Kirsch, D.E., Grodin, E.N., Nieto, S.J. Kady, A., & Ray, L. Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder. Neuropsychopharmacol. (2024). https://doi.org/10.1038/s41386-024-01877-4
7. Addiction Cue-Reactivity Initiative (ACRI) Network, Sangchooli, A., Zare-Bidoky, M., Fathi Jouzdani, A., Schacht, J., Bjork, J. M., Claus, E. D., Prisciandaro, J. J., Wilson, S. J., Wüstenberg, T., Potvin, S., Ahmadi, P., Bach, P., Baldacchino, A., Beck, A., Brady, K. T., Brewer, J. A., Childress, A. R., Courtney, K. E., Ebrahimi, M., … Ekhtiari, H. (2024). Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review. JAMA psychiatry, 81(4), 414–425. https://doi.org/10.1001/jamapsychiatry.2023.5483
8. Nieto, S. J., Grodin, E. N., & Ray, L. A. (2024). Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder. Behavioural brain research, 464, 114926. https://doi.org/10.1016/j.bbr.2024.114926
9. Baskerville, A., Grodin, E., & Ray, A. Influence of sleep quality on lapse to alcohol use during a quit attempt, Alcohol and Alcoholism, Volume 59, Issue 2, March 2024, agae009, https://doi.org/10.1093/alcalc/agae009
10. Grodin, E. N., Kady, A., & Ray, L. A. (2024). The future of reward and relief drinking profiles: Considerations for social motives, stability of profiles, and tailored interventions. Alcohol: Clinical and Experimental Research, 48(3), 462–465. https://doi.org/10.1111/acer.15269
11. Grodin, E.N., Kirsch, D., Belnap, M. & Ray, L.A. (2024) Sex differences in neural response to an acute stressor in individuals with an alcohol use disorder. Alcohol: Clinical and Experimental Research, 48, 843–854. Available from: https://doi.org/10.1111/acer.15301
12. Grodin, E. N., Baskerville, W. A., Meredith, L. R., Nieto, S., & Ray, L. A. (2024). Reward, relief, and habit drinking profiles in treatment seeking individuals with an AUD. Alcohol and alcoholism (Oxford, Oxfordshire), 59(3), agae032. https://doi.org/10.1093/alcalc/agae032
13. Grodin, E.N., Burnette, E.M., Rodriguez, C., Fulcher, J.A. & Ray, L.A. (2024) The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies. Alcohol: Clinical and Experimental Research, 48, 1221–1242. https://doi.org/10.1111/acer.15338
14. Kady, A., Grodin, E. N., & Ray, L. A. (2024). Characterizing reward and relief/habit drinking profiles in a study of naltrexone, varenicline, and placebo. Alcohol and alcoholism (Oxford, Oxfordshire), 59(4), agae044. https://doi.org/10.1093/alcalc/agae044
15. Burnett, D. P., Trikalinos, T. A., Kiluk, B. D., Ray, L., Misquith, C., & Magill, M. (2024). A Descriptive Review and Meta-Regression Study of Demographic and Study Context Factors in US Clinical Trials of Cognitive Behavioral Interventions for Alcohol or Other Drug Use. Substance use & misuse, 1–11. Advance online publication. https://doi.org/10.1080/10826084.2024.2369167
16. Simpson, K. A., Stone, M. D., Leventhal, A. M., Pang, R. D., Ray, L., & Kirkpatrick, M. G. (2024). Effects of intranasal oxytocin on cigarette withdrawal and smoking in the laboratory: Differences by sex and social functioning traits. Experimental and Clinical Psychopharmacology. Advance online publication. https://doi.org/10.1037/pha0000733
17. Donato, S., Meredith, L. R., Nieto, S. J., Bujarski, S., & Ray, L. A. (2024). Medication development for AUD: A systematic review of clinical trial methodology. Alcohol (Fayetteville, N.Y.), S0741-8329(24)00093-4. Advance online publication. https://doi.org/10.1016/j.alcohol.2024.06.007
18. Belnap, M. A., McManus, K. R., Grodin, E. N., & Ray, L. A. (2024). Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder. Pharmaceutical medicine, 38(4), 291–302. https://doi.org/10.1007/s40290-024-00526-x
19. Kirsch, D. E., Grodin, E. N., & Ray, L. A. (2024). Characterizing alcohol cue reactive and non-reactive individuals with alcohol use disorder. Addictive behaviors, 155, 108028. https://doi.org/10.1016/j.addbeh.2024.108028
20. Grodin EN, McManus KR, Ray LA. Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder. Addiction Biology. 2024; 29(8):e13431. doi:10.1111/adb.13431
21. Heilig, M., Witkiewitz, K., Ray, L. A., & Leggio, L. (2024). Novel medications for problematic alcohol use. The Journal of clinical investigation, 134(11), e172889. https://doi.org/10.1172/JCI172889

2023 _______________________________________________________

1. Ray, L.A., Nieto, S.J., Meredith, L.R. et al. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study. Psychopharmacology 240, 1921–1930 (2023). https://doi.org/10.1007/s00213-023-06409-4
2. Donato, S., & Ray, L. A. (2023). Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base. Substance abuse and rehabilitation, 14, 157–166. https://doi.org/10.2147/SAR.S409943
3. Meredith, L.R., Burnette, E.M., Nieto, S.J., Du, H., Donato, S., Grodin, E.N. et al. (2023) Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol: Clinical and Experimental Research, 47, 1629–1645. https://doi.org/10.1111/acer.15143
4. Magill, M., Kiluk, B. D., & Ray, L. A. (2023). Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate?. Substance abuse and rehabilitation, 14, 1–11. https://doi.org/10.2147/SAR.S362864
5. Meredith, L. R., Hurley, B., Friedman, T. C., Lee, M. L., Rodriguez, L., Lopez, B., Mtume, N., Dixon, T., Belani, H. K., Hsieh, S., & Ray, L. A. (2023). Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices. Journal of addiction medicine, 17(6), 677–684. https://doi.org/10.1097/ADM.0000000000001211
6. Lékó, A. H., Ray, L. A., & Leggio, L. (2023). The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?. Alcohol, clinical & experimental research, 47(5), 843–847. https://doi.org/10.1111/acer.15049
7. Nieto, S.J., Donato, S., Gillis, A.J., Ray, L.A. (2023). Laboratory Based Approaches to Medications Development for Alcohol Addiction. In: Mueller, S., Heilig, M. (eds) Alcohol and Alcohol-related Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-32483-3_21
8. Grodin, E.N., Meredith, L.R., Burnette, E.M., Ray, L.A. (2023). Brain-Immune Mechanisms in Alcohol Use Disorder Targeting Neuroimmune Signaling in Alcohol Use Disorder: Opportunities for Translation. In: Mueller, S., Heilig, M. (eds) Alcohol and Alcohol-related Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-32483-3_30
9. Grodin, E. N., Meredith, L. R., Burnette, E. M., Miotto, K., Irwin, M. R., & Ray, L. A. (2022). Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. The American Journal of Drug and Alcohol Abuse, 49(3), 333–344. https://doi.org/10.1080/00952990.2022.2124918
10. Burnette, E.M., Grodin, E.N., Olmstead, R., Ray, L.A. & Irwin, M.R. (2023) Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge. Alcohol: Clinical and Experimental Research, 47, 1859–1868. https://doi.org/10.1111/acer.15173
11. Baskerville, W. A., Grodin, E. N., Lin, J., Miotto, K., Mooney, L. J., & Ray, L. A. (2023). Alcohol Use Among Treatment-Seeking Individuals With Opioid Use Disorder. Journal of studies on alcohol and drugs, 84(4), 579–584. https://doi.org/10.15288/jsad.22-00176
12. Burnette, E.M., Nieto, S.J., Grodin, E.N., Jentsch, J.D., Ray, L.A. (2023). Intravenous Alcohol Self-Administration Using a Progressive Ratio Schedule of Reinforcement in Clinical Studies. In: Cyders, M.A. (eds) Translational Research Methods for Alcohol Use Disorders. Neuromethods, vol 201. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3267-3_10
13. Levitt EE, Oshri A, Amlung M, et al. Evaluation of delay discounting as a transdiagnostic research domain criteria indicator in 1388 general community adults. Psychological Medicine. 2023;53(4):1649-1657. doi:10.1017/S0033291721005110
14. Venegas, A., & Ray, L. A. (2023). Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach. Experimental and Clinical Psychopharmacology, 31(3), 683–693. https://doi.org/10.1037/pha0000621
15. Ray, L. A., Nieto, S. J., & Grodin, E. N. (2023). Translational models of addiction phenotypes to advance addiction pharmacotherapy. Ann NY Acad Sci., 1519, 118–128. https://doi.org/10.1111/nyas.14929

2022 _______________________________________________________

1. Nieto, S. J., Grodin, E. N., Burnette, E. M., Cahill, C. M., & Ray, L. A. (2022). Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder. Alcohol and Alcoholism.
2. Grodin, E. N., Nieto, S. J., Meredith, L. R., Burnette, E., O’Neill, J., Alger, J., London, E. D., Miotto, K., Evans, C. J., Irwin, M. R., & Ray, L. A. (2022). Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addiction Biology, 27(4), e13182.
3. Baskerville, W. A., Grodin, E. N., Venegas, A., & Ray, L. A. (2022). Global Sleep Quality is Associated with Tonic Craving, but Not Cue-Induced Craving. Addictive Behaviors, 107372.
4. Leventhal, A. M., Cho, J., Ray, L. A., Liccardo Pacula, R., Lee, B. P., Terrault, N., Pederson, E., Lee, J. O., Davis, J. P., Jin, H., Huh, J., Wilson, J. P., & Whaley, R. C. (2022). Alcohol use trajectories among US adults during the first 42 weeks of the COVID‐19 pandemic. Alcoholism: clinical and experimental research.
5. Nieto, S. J., Venegas, A., Hudson, J., & Ray, L. A. (2022). Cannabis use and subjective response to alcohol in the human laboratory. Drug and Alcohol Dependence, 236, 109481.
6. Green, R., Roche, D. J., & Ray, L. A. (2022). The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers. Alcohol and Alcoholism.
7. Nieto, S. J., & Ray, L. A. (2022). Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Behavioural Brain Research, 427, 113876.
8. Meredith, L. R., Grodin, E. N., Montoya, A. K., Miranda Jr, R., Squeglia, L. M., Towns, B., Evans, C., & Ray, L. A. (2022). The effect of neuroimmune modulation on subjective response to alcohol in the natural environment. Alcoholism: Clinical and Experimental Research.
9. Grodin, E. N., Donato, S., Du, H., Green, R., Bujarski, S., & Ray, L. A. (2022). A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol and Alcoholism.
10. Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022). Novel agents for the pharmacological treatment of alcohol use disorder. Drugs, 1-24.
11. Ekhtiari, H., Zare-Bidoky, M., Sangchooli, A., Janes, A. C., Kaufman, M. J., Oliver, J. A., Ray, L. A., Prisciandaro, J. J., Wüstenberg, T., Anton, R. F., Bach, P., Baldacchino, A., Beck, A., Bjork, J. M., Brewer, J., Childress, A. R.,Claus, Courtney, K. E., Ebrahimi, M., Goudriaan, A. E., E. D…& Zilverstand, A. (2022). A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nature Protocols, 17(3), 567-595.
12. Baskerville, W. A., Friedman, T. C., Hurley, B., Hsieh, S., Dixon, T., Mtume, N., Lee, M. L., Rodriguez, L., Lopez, B., & Ray, L. A. (2022). Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial. Trials, 23(1), 1-13.
13. Nieto, S. J., Grodin, E. N., Ho, D., Baskerville, W. A., & Ray, L. A. (2022). Moderators of subjective response to alcohol in the human laboratory. Alcoholism: Clinical and Experimental Research, 46(3), 468-476.
14. Nieto, S. J., Venegas, A., Burnette, E. M., MacKillop, J., & Ray, L. A. (2022). Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers. Psychopharmacology, 239(5), 1387-1395.

2021 _______________________________________________________

1. Baskerville, W. A., Nieto, S. J., Ho, D., Towns, B., Grodin, E. N., Li, C., Li, C., Burnette, E., Donato, S., & Ray, L. A. (2021). Baseline Drinking Patterns in Non-Treatment Seeking Problem Drinkers. Alcohol and Alcoholism, 56(1), 57-63.
2. Green, R., Montoya, A. K., & Ray, L. A. (2021). The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reduction. Experimental and Clinical Psychopharmacology.
3. Meredith, L. R., Baskerville, W. A., Friedman, T. C., Hurley, B., Dixon, T., Mtume, N., Rodriguez, L., Lopez, B., Hsieh, S., & Ray, L. A. (2021). Safety Net Provider Attitudes Toward Smoking Cessation Treatment. Frontiers in Psychiatry, 12, 744816.
4. Nieto, S. J., Grodin, E. N., Aguirre, C. G., Izquierdo, A., & Ray, L. A. (2021). Translational opportunities in animal and human models to study alcohol use disorder. Translational psychiatry, 11(1), 1-14.
5. Burnette, E. M., Ray, L. A., Irwin, M. R., & Grodin, E. N. (2021). Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder. Alcoholism: Clinical and Experimental Research, 45(10), 2017-2028.
6. Donato, S., Green, R., & Ray, L. A. (2021). Alcohol use disorder severity moderates clinical response to varenicline. Alcoholism: Clinical and Experimental Research, 45(9), 1877-1887.
7. Venegas, A., Donato, S., Meredith, L. R., & Ray, L. A. (2021). Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. The American Journal of Drug and Alcohol Abuse, 47(6), 664-679.
8. Grodin, E. N., Burnette, E., Towns, B., Venegas, A., & Ray, L. A. (2021). Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers. Psychology of Addictive Behaviors, 35(6), 760.
9. Meredith, L. R., Grodin, E. N., Karno, M. P., Montoya, A. K., MacKillop, J., Lim, A. C., & Ray, L. A. (2021). Preliminary study of alcohol problem severity and response to brief intervention. Addiction science & clinical practice, 16(1), 1-12.
10. Meredith, L. R., Burnette, E. M., Grodin, E. N., Irwin, M. R., & Ray, L. A. (2021). Immune treatments for alcohol use disorder: A translational framework. Brain, Behavior, and Immunity, 97, 349-364.
11. Leventhal, A. M., Conti, D. V., Ray, L. A., Baurley, J. W., Bello, M. S., Cho, J., Zhang, Y., Pester, M.S., Lebovitz, L., Budiarto, A., Mahesworo, B., & Pardamean, B. (2021). A genetic association study of tobacco withdrawal endophenotypes in African Americans. Experimental and Clinical Psychopharmacology.
12. Grodin, E. N., Burnette, E. M., Green, R., Lim, A. C., Miotto, K., & Ray, L. A. (2021). Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. Drug and Alcohol Dependence, 225, 108825.
13. Ray, L. A., Green, R., & Grodin, E. (2021). Neurobiological models of alcohol use disorder in humans. American Journal of Psychiatry, 178(6), 483-484.
14. Nieto, S. J., Baskerville, W., Donato, S., Bujarski, S., & Ray, L. (2021). Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. The American Journal of Drug and Alcohol Abuse, 47(5), 630-637.
15. Green, R., Du, H., Grodin, E. N., Nieto, S. J., Bujarski, S., Roche, D. J., & Ray, L. A. (2021). A meta‐regression of methodological features that predict the effects of medications on the subjective response to alcohol. Alcoholism: Clinical and Experimental Research, 45(7), 1336-1347.
16. Grodin, E. N., Bujarski, S., Towns, B., Burnette, E., Nieto, S., Lim, A., Lin, J., Miotto, K., Gillis, A., Irwin, M. R., Evans, C., & Ray, L. A. (2021). Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational psychiatry, 11(1), 1-8.
17. Ray, L. A., Green, R., Enders, C., Leventhal, A. M., Grodin, E. N., Li, G., Lim, A., Hartwell, E., Venegas, A., Meredith, L., Nieto, S. J., Shoptaw, S., Ho, D., & Miotto, K. (2021). Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction: a randomized clinical trial. American Journal of Psychiatry, 178(9), 818-828.
18. Mehta, K., Hoadley, A., Ray, L. A., Kiluk, B. D., Carroll, K. M., & Magill, M. (2021). Cognitive-behavioral interventions targeting alcohol or other drug use and co-occurring mental health disorders: a meta-analysis. Alcohol and Alcoholism, 56(5), 535-544.
19. Mehta, K., Hoadley, A., Ray, L. A., Kiluk, B. D., Carroll, K. M., & Magill, M. (2021). ” Cognitive-behavioral interventions targeting alcohol or other drug use and co-occurring mental health disorders: A meta-analysis”: Erratum.
20. Nieto, S. J., Grodin, E. N., Green, R., & Ray, L. A. (2021). Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug and alcohol dependence, 221, 108603.
21. Burnette, E. M., Grodin, E. N., Eisenberger, N. I., & Ray, L. A. (2021). Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge. Alcohol and Alcoholism, 56(6), 715-717.
22. Ray, L. A., & Grodin, E. N. (2021). Clinical neuroscience of addiction: what clinical psychologists need to know and why. Annual Review of Clinical Psychology, 17, 465-493.
23. Green, R., MacKillop, J., Hartwell, E. E., Lim, A. C., Baskerville, W. A., Karno, M., & Ray, L. A. (2021). Behavioral economic demand for alcohol and cigarettes in heavy drinking smokers: evidence of asymmetric cross-commodity reinforcing value. Nicotine and Tobacco Research, 23(4), 748-755.
24. Ray, L. A., Du, H., Green, R., Roche, D. J., & Bujarski, S. (2021). Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology, 46(3), 519-527.
25. Burnette, E. M., Grodin, E. N., Ghahremani, D. G., Galvan, A., Kohno, M., Ray, L. A., & London, E. D. (2021). Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and alcohol dependence, 218, 108391.
26. Nieto, S. J., Green, R., Grodin, E. N., Cahill, C. M., & Ray, L. A. (2021). Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug and alcohol dependence, 218, 108368.
27. Burnette, E. M., Grodin, E. N., Schacht, J. P., & Ray, L. A. (2021). Clinical and neural correlates of reward and relief drinking. Alcoholism: Clinical and Experimental Research, 45(1), 194-203.
28. Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H., Feldstein Ewing, S. W., Jentsch, J. D., King, A. C., Mason, B. J., O’Malley S., Heilig, M., Koob, G. F., & MacKillop, J. (2021). The future of translational research on alcohol use disorder. Addiction Biology, e12903.
29. Bello, M. S., Liautaud, M. M., De La Cerda, J. T., Pang, R. D., Ray, L. A., Ahluwalia, J. A., & Leventhal, A. M. (2021). Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans. Addiction, 116(4), 914-925.
30. Venegas, A., Meredith, L. R., Green, R., Cooper, Z. D., & Ray, L. A. (2021). Sex-dependent effects of alcohol administration on the urge to use cannabis. Experimental and clinical psychopharmacology.

2020 _______________________________________________________

1. Cummings, J. R., Ray, L. A., Nooteboom, P., & Tomiyama, A. J. (2020). Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking. Annals of Behavioral Medicine, 54(2), 132-138.
2. Venegas, A., & Ray, L. A. (2020). Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. The American journal of drug and alcohol abuse, 46(1), 131-138.
3. Ray, L. A., Du, H., Grodin, E., Bujarski, S., Meredith, L., Ho, D., … & Wassum, K. (2020). Capturing habitualness of drinking and smoking behavior in humans. Drug and Alcohol Dependence, 207, 107738.
4. Grodin, E. N., Nguyen, X. T., Ho, D., Bujarski, S., & Ray, L. A. (2020). Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers. Addictive Behaviors Reports, 100249.
5. Aguirre, C. G., Stolyarova, A., Das, K., Kolli, S., Marty, V., Ray, L., … & Izquierdo, A. (2020). Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal. bioRxiv.
6. Nieto, S. J., Grodin, E. N., & Ray, L. A. (2020). On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medications. Expert Review of Precision Medicine and Drug Development, 5(1), 43-54.
7. Glasner, S., Chokron Garneau, H., Ang, A., Ray, L., Venegas, A., Rawson, R., & Kalichman, S. (2020). Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial. PloS one, 15(3), e0229557.
8. Grodin, E., Montoya, A., Bujarski, S., & Ray, L. (2020). Modeling Motivation for Alcohol in Humans using Traditional and Machine Learning Approaches.
9. Venegas, A., Meredith, L. R., Cooper, Z. D., Towns, B., & Ray, L. A. (2020). Inclusion of cannabis users in alcohol research samples: screening in, screening out, and implications. Alcohol and alcoholism.
10. Lim, A. C., Grodin, E. N., Green, R., Venegas, A., Meredith, L. R., Courtney, K. E., … & Ray, L. A. (2020). Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. The American Journal of Drug and Alcohol Abuse, 1-12.
11. Lim, A. C., Green, R., Grodin, E. N., Venegas, A., Meredith, L. R., Donato, S., … & Ray, L. A. (2020). Alcohol Cue–Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self‐Administration. Alcoholism: Clinical and Experimental Research.
12. Magill, M., Tonigan, J. S., Kiluk, B., Ray, L., Walthers, J., & Carroll, K. (2020). The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review. Behaviour Research and Therapy, 103648.
13. Kramer, J., Dick, D. M., King, A., Ray, L. A., Sher, K. J., Vena, A., … & Acion, L. (2020). Mechanisms of Alcohol Addiction: Bridging Human and Animal Studies. Alcohol and Alcoholism, 55(6), 603-607.
14. Grodin, E. N., Green, R., & Ray, L. A. (2020). An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol. Alcoholism: Clinical and Experimental Research, 44(11), 2298-2306.
15. Nieto, S. J., Green, R., MacKillop, J., & Ray, L. A. (2020). Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals with Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research, 44(11), 2336-2342.
16. Meredith, L. R., Lim, A. C., & Ray, L. A. (2020). Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences. Drug and Alcohol Dependence, 216, 108269.
17. Burnette, E. M., Baskerville, W. A., Grodin, E. N., & Ray, L. A. (2020). Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial. Trials, 21(1), 1-19.
18. Ho, D., Towns, B., Grodin, E. N., & Ray, L. A. (2020). A novel human laboratory model for screening medications for alcohol use disorder. Trials, 21(1), 1-13.
19. Burnette, E. M., Grodin, E. N., Ghahremani, D. G., Galvan, A., Kohno, M., Ray, L. A., & London, E. D. (2020). Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and alcohol dependence, 108391.
20. Nieto, S. J., Green, R., Grodin, E. N., Cahill, C. M., & Ray, L. A. (2020). Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug and alcohol dependence, 218, 108368.
21. Ray, L. A., Du, H., Green, R., Roche, D. J., & Bujarski, S. (2020). Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology, 1-9.
22. Green, R., MacKillop, J., Hartwell, E. E., Lim, A. C., Baskerville, W. A., Karno, M., & Ray, L. A. (2020). Behavioral Economic Demand for Alcohol and Cigarettes in Heavy Drinking Smokers: Evidence of Asymmetric Cross-commodity Reinforcing Value. Nicotine & Tobacco Research.

2019 _______________________________________________________

1. Grodin, E.N., Ray, L.A., MacKillop, J., Lim, A.C., & Karno, M.P. (2019) Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcoholism: Clinical and Experimental Research, 43(2), 367-377.
2. Green, R., Bujarski, S., Lim, A.C., Venegas, A., & Ray, L.A. (2019) Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Experimental and Clinical Psychopharmacology, 27(3), 257-264.
3. Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., … & Galloway, G. (2019). Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety. Alcoholism: Clinical and Experimental Research, 43(1), 158-169.
4. Green, R., Grodin, E., Lim, A. C., Venegas, A., Bujarski, S., Krull, J., & Ray, L. A. (2019). The interplay between subjective response to alcohol, craving, and alcohol self‐administration in the human laboratory. Alcoholism: Clinical and Experimental Research, 43(5), 907-915.
5. Grodin, E. N., Courtney, K. E., & Ray, L. A. (2019). Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity. Journal of studies on alcohol and drugs, 80(2), 245-251.
6. Ray, L. A., Lim, A. C., & Shoptaw, S. (2019). What defines a clinically meaningful outcome in the treatment of substance use disorders:‘Getting your life back’. Addiction, 114(1), 18-20.
7. Ray, L. A., Bujarski, S., Grodin, E., Hartwell, E., Green, R., Venegas, A., … & Miotto, K. (2019). State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American journal of drug and alcohol abuse, 45(2), 124-140.
8. Roche, D. J. O., Bujarski, S., Green, R., Hartwell, E. E., Leventhal, A. M., & Ray, L. A. (2019). Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co-and tri-use. Drug and alcohol dependence, 200, 40-49.
9. Grodin, E. N., & Ray, L. A. (2019). The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review. Alcoholism: Clinical and Experimental Research, 43(10), 2038-2056.
10. Kiluk, B. D., Ray, L. A., Walthers, J., Bernstein, M., Tonigan, J. S., & Magill, M. (2019). Technology‐Delivered Cognitive‐Behavioral Interventions for Alcohol Use: A Meta‐Analysis. Alcoholism: clinical and experimental research, 43(11), 2285-2295.
11. Grodin, E. N., Bujarski, S., Venegas, A., Baskerville, W. A., Nieto, S. J., Jentsch, J. D., & Ray, L. A. (2019). Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol and Alcoholism, 54(6), 574-583.
12. Hartwell, E. E., Bujarski, S., Green, R., & Ray, L. A. (2019). Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving.Addictive Behaviors Reports, 10, 100198.
13. Burnette, E. M., Grodin, E. N., Lim, A. C., MacKillop, J., Karno, M. P., & Ray, L. A. (2019). Association between impulsivity and neural activation to alcohol cues in heavy drinkers. Psychiatry Research: Neuroimaging, 293, 110986.
14. Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K. (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of consulting and clinical psychology, 87(12), 1093.
15. Ray, L. A., Green, R., Roche, D. J., Magill, M., & Bujarski, S. (2019). Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis. Addiction biology, 24(6), 1138-1152.
16. Cummings, J. R., Gearhardt, A. N., Ray, L. A., Choi, A. K., & Tomiyama, A. J. (2019). Experimental and observational studies on alcohol use and dietary intake: a systematic review. Obesity Reviews.
17. Cortland, C. I., Shapiro, J. R., Guzman, I. Y., & Ray, L. A. (2019). The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology. Addiction, 114(10), 1842-1848.
18. Lim, A. C., Ghahremani, D. G., Grodin, E. N., Green, R., Bujarski, S., Hartwell, E. E., … & Ray, L. A. (2019). Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug and alcohol dependence, 200, 181-190.
19. Grodin, E. N., Lim, A. C., MacKillop, J., Karno, M. P., & Ray, L. A. (2019). An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Frontiers in psychiatry, 10, 408.

2018 _______________________________________________________

1. Garneau, H. C., Venegas, A., Rawson, R., Ray, L. A., & Glasner, S. (2018). Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. Journal of Substance Abuse Treatment, 85, 34-37.
2. Hartwell, E.E., & Ray, L.A. (2018). Craving as a DSM-5 symptom of alcohol use disorder in non-treatment seekers. Alcohol & Alcoholism, 14, 1-6.
3. Ray, L.A., Green, R., Roche, D.J.O., Bujarski, S., Hartwell, E., Lim, A., Rohrbaugh, T., Ghahremani, D., Hutchison, K.E., Miotto, K. (2018). Pharmacogenetic effects of naltrexone in individuals of East Asian descent: Human Laboratory Findings from a Randomized Trial. Alcoholism: Clinical and Experimental Research, 42(3), 613-623.
4. Moallem, N.R., Courtney, K.E., & Ray, L.A. (2018). The relationship between impulsivity and methamphetamine use severity in a community sample. Drug and Alcohol Dependence, 187, 1-7.
5. Green, R. & Ray, L.A. (2018). Effects of varenicline on subjective craving and relative reinforcing value of cigarettes. Drug and Alcohol Dependence, 188, 53-59.
6. Hartwell, E. & Ray, L.A. (2018). Relationship between tonic and phasic craving for alcohol. Addictive Behavior Reports, 7, 71-74.
7. Bujarski, S., Jentsch, J.D., Roche, D.J.O., Ramchandani, V.A., Miotto, K., & Ray, L.A. (2018) Differences in the subjective and motivational properties of alcohol across alcohol use disorder severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology, 43(9), 1891-1899.
8. Ray, L. A., & Roche, D.J.O. (2018). Neurobiology of Craving: Current Findings and New Directions. Current Addiction Reports, 5(2), 102-109.
9. Cummings, J. R., Tomiyama, A. J., & Ray, L.A. (2018). Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. Journal of Addiction Medicine. 12(5), 410-417.
10. Bello, M.S., McBeth, J.F., Ditre, J.W., Kirkpatrick, M.G., Ray, L.A., Dunn, K.E., & Leventhal, A.M. (2018). Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. Journal of Abnormal Psychology, 127(7) 683-694.
11. Allen, V.C., Ray, L.A., & Myers, H.F. (2018). Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcoholism: Clinical & Experimental Research, 42(8), 1548-1555.
12. Ray, L.A., Bujarski, S., Roche, D.J.O., & Magill, M. (2018) Overcoming the “Valley of Death” in medications development for alcohol use disorder. Alcoholism: Clinical & Experimental Research, 42(9), 1612-1622.
13. Lim, A.C., Courtney, K.E., Moallem, N.R., Allen, V.C., Leventhal, A.M., & Ray, L.A. (2018) A brief smoking cessation intervention for heavy drinking smokers: Treatment development, feasibility, and preliminary results. Frontiers in Psychiatry, 9, 362.
14. Lim, A.C., Roche, D.J.O., & Ray, L.A. (2018) Distress tolerance and craving for cigarettes among heavy drinking smokers. Journal of Studies on Alcohol and Drugs, 79(6), 918-928.
15. Ray, L.A., Bujarski, S., Grodin, E.N., Hartwell, E.E., Green, R., & Venegas, A. (2018) State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse, 1-17. 

2017 _______________________________________________________

1. Bujarski, S., Hutchison, K.E., Prause, N., & Ray, L.A. (2017). Functional Significance of Subjective Response to Alcohol across Levels of Alcohol Exposure. Addiction Biology, 22(1), 235-45.
2. Cservenka, A. & Ray, L.A. (2017). Self-reported attentional and motor impulsivity are related to age at first methamphetamine use. Addictive Behaviors, 65, 7-12.
3. Cummings, J.R., Ray, L.A., & Tomiyama, A.J. (2017). Food-alcohol competition: As young females eat more food, do they drink less alcohol? Journal of Health Psychology, 22(5), 674-683.
4. Yardley, M., & Ray, L.A. (2017). Medications development for the treatment of alcohol use disorder: Insights into the predictive value of animal paradigms and human laboratory models. Addiction Biology, 22(3), 581-615.
5. Bello, M.S., Pang, R.D., Chasson, G.S., Ray, L.A., & Leventhal, A.M. (2017). Obsessive-Compulsive Symptoms and Negative Affect During Tobacco Withdrawal in a Non-Clinical Sample of African American Smokers. Journal of Anxiety Disorders, 48, 78-86. 
6. Cservenka, A., Yardley, M.M., & Ray, L.A. (2017). Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. The American Journal on Addictions, 26(5), 516-525. 
7. Bullock, K., Cservenka, A., & Ray, L.A. (2017). Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. American Journal of Drug and Alcohol Abuse, 43(3), 281-290.
8. Westman, J., Bujarski, S.E., & Ray, L.A. (2017). Impulsivity moderates subjective responses to alcohol in alcohol dependent individuals. Alcohol & Alcoholism, 52(2), 249-255.
9. Lim, A., Cservenka, A., & Ray, L.A. (2017). Effects of alcohol dependence severity on neural correlates of delay discounting. Alcohol & Alcoholism, 52(4), 506-515. 
10. Ray, L.A., Bujarski, S.E., Shoptaw, S., Roche, D.J.O., Heinzerling, K., & Miotto, K. (2017). Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: A randomized, placebo-controlled, human laboratory trial. Neuropsychopharmacology, 42, 1776-1788. 
11. Ray, L.A., Bujarski, S., Yardley, M.M., Roche, D.J.O., & Hartwell, E. (2017). Differences between treatment-seeking and non-treatment seeking participants in medication studies for alcoholism: Do they matter? American Journal of Drug and Alcohol Abuse, 43, 703-710.
12. Roche, D.J.O., Worley, M., Courtney, K., Bujarski, S., London, E., Shoptaw, S., Ray, L.A. (2017). Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology, 234(13), 1997-2007.
13. Cservenka, A., Courtney, K., Ghahremani, D., Hutchison, K.E., & Ray, L.A. (2017). Development, initial testing, and challenges of an ecologically valid reward prediction error fMRI task for alcoholism. Alcohol & Alcoholism, 52(5), 617-624. 

2016 _______________________________________________________

1. Ray, L.A., Bujarski, S., & Roche D.J.O. (2016) Subjective Response to Alcohol as a Research Domain Criterion. Alcoholism: Clinical and Experimental Research, 40(1), 6-17.
2. Squeglia, L. M., Brammer, W. A., Ray, L. A., & Lee, S. S. (2016). Attention-deficit/hyperactivity disorder (ADHD) symptoms predict alcohol expectancy development. Journal of Child and Adolescent Substance Abuse, 25(2), 169-179.
3. Moore, A.A., Karno, M.P., Ray, L.A., Ramirez, K., Barenstein, V., Portillo, M., Rizo, P., Borok, J., Liao, D.H., Barron, J., Del Pino, H.E., Valenzuela, A., Barry, K.L. (2016). Development and preliminary testing of a promotora-delivered, Spanish language, counseling intervention for unhealthy drinking among male, Latino day laborers. Journal of Substance Abuse Treatment, 62, 96-101.
4. Inagaki, T.K., Ray, L.A., Irwin, M.R., Way, B.M., Eisenberger, N.I. (2016). Opioids and social bonding: Naltrexone reduces feelings of social connection. Social Cognitive and Affective Neuroscience, 11(5), 728-735.
5. Courtney, K.E., & Ray, L.A. (2016). Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Progress in Brain Research, 223, 295-310.
6. Bacio, G.A. & Ray, L.A. (2016). Patterns of drinking initiation among Latino youths: Cognitive and contextual explanations of the immigrant paradox. Journal of Child & Adolescent Substance Abuse, 1-11.
7. Roche, D.J.O., Ray, L.A., Yardley, M.M., & King, A.C. (2016). Current insights into the mechanisms and treatments for heavy-drinking cigarette smokers. Current Addiction Reports, 3(1), 125-137.
8. Roche, D.J.O., Lunny, K.F., Yardley, M.M., Louie, S.G., Davies, D.L., Miotto K., & Ray L.A. (2016). A Pilot study of the safety and initial efficacy of ivermectin for the treatment of alcohol use disorder. Alcoholism: Clinical and Experimental Research, 40(6), 1312-1320.
9. Green, R., Bujarski, S., Roche, D.J.O., & Ray, L.A. (2016). Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors, 61, 53-57.
10. Chung, T., Noronha, A., Carroll, K.M., Potenza, M.N., Hutchison, K., Calhoun, V.D., Gabrieli, J.D.E., Morgenstern, J., Nixon, S.J., Wexler, B.E., Brewer, J., Ray, L.A., Filbey, F., Strauman, T.J., Kober, H., & Feldstein Ewing, S.W. (2016). Brain Mechanisms of Change in Addiction Treatment: Models, Methods, and Emerging Findings. Current Addiction Reports, 3(3), 332-342.
11. Bujarski, S. & Ray, L.A. (2016). Experimental psychopathology paradigms for alcohol use disorder: Applications for translational research. Behaviour Research and Therapy, 86, 11-22.
12. Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2016). The effects of pharmacological opioid blockade on neural measures of drug cue-reactivity in humans. Neuropsychopharmacology, 41(12), 2872-2881.
13. Hartwell, E.E., Moallem, N.R., Courtney, K.E., Glasner-Edwards, S., & Ray, L.A. (2016). Sex differences in the association between internalizing symptoms and craving in methamphetamine users. Journal of Addiction Medicine, 10(6), 395-401.

2015 _______________________________________________________

1. Roche D.J.O., Ray L.A. (2015). Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics, 16(7), 721-36.
2. Owens, M., Ray, L.A., & MacKillop, J. (2015). Behavioral economic analysis of stress effects on acute motivation for alcohol. Journal of the Experimental Analysis of Behavior, 103(1), 77-86.
3. Bujarski, S., Hutchison, K.E., Roche, D.J.O. & Ray, L.A. (2015). Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcoholism: Clinical and Experimental Research, 39(7), 1193-1202. 
4. Roche D.J.O., Bujarski S, Hartwell E, Green R, & Ray L.A. (2015). Combined Varenicline and Naltrexone Treatment reduces Smoking Topography Intensity in Heavy-Drinking Smokers. Pharmacology, Biochemistry and Behavior, 134, 92-98. 
5. Ray, L.A., Bujarski, S.E., Courtney, K.E., Moallem, N.R., Lunny, K., Roche, D.J.O., Leventhal, A.,Shoptaw, S., Heinzerling, K., London, E.D., & Miotto, K. (2015). The effects of naltrexone on subjective response to methamphetamine in a clinical sample: A double-blind, placebo-controlled, laboratory study. Neuropsychopharmacology, 1-10.
6. Sheets, E.S., Bujarski, S., Leventhal, A., & Ray, L.A. (2015) Emotion Differentiation and Intensity during Acute Tobacco Abstinence: A Comparison of Heavy and Light Smokers. Addictive Behaviors. 47, 70-73.
7. Bujarski, S., Roche, D.J.O., Sheets, E.S., Krull, J.L., Guzman I., & Ray, L.A. (2015) Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: a pilot EMA study. Experimental and Clinical Psychopharmacology. 23(2) 81 – 89.
8. Allen, V. Myers, H.F., & Ray, L.A. (2015). The association between alcohol consumption and condom use: Considering correlates of HIV risk among Black men who have sex with men. AIDS & Behavior, 19(9), 1689-1700.
9. Bidwell, L.C., Knopik, V.S., Audrain-McGovern,J., Glynn, T.R., Spillane, N.S., Ray, L.A., Riggs, N.R., Guillot, C., Pang,R.D., & Leventhal, A.M. (2015). Novelty seeking as a phenotypic marker of adolescent substance use. Substance Abuse: Research and Treatment, 9(Suppl 1), 1-10.
10. Yardley, M.M., Mirbaba, M.M., & Ray, L.A. (2015). Pharmacological options for smoking cessation in heavy-drinking smokers. CNS Drugs, 29(10), 833-845.
11. Hartwell, E.E., Bujarski, S., Glasner-Edwards, S., & Ray, L.A. (2015). The association of alcoholism severity with sleep quality in problem alcohol users. Alcohol & Alcoholism, 50(5), 536-541.
12. Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A. & London, E.D. (2015). Varenicline, naltrexone, and their combination for heavy drinking smokers: Preliminary neuroimaging findings. American Journal of Drug and Alcohol Abuse, 41(1), 35-44.
13. Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2015). The effect of alcohol priming on neural markers of alcohol cue-reactivity. American Journal of Drug and Alcohol Abuse, 41(4), 300-308.
14. Bujarski, S.E., Lau, A., Lee, S., & Ray, L.A. (2015). Genetic and environmental predictors of alcohol use in Asian American young adults. Journal of Studies on Alcohol and Drugs, 76(5), 690-699.
15. Ray, L.A. & Bujarski,S.E. (2015). Mechanisms of topiramate effects: Refining medications development for alcoholism. Addiction Biology, 21(1), 183-84.